Publisher
Springer Science and Business Media LLC
Reference109 articles.
1. Velenosi TJ, Urquhart BL (2014) Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis. Expert Opin Drug Metab Toxicol 10(8):1131–1143
2. Agarwal R, Cronin RE (1994) Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers. Am J Kidney Dis janv 23(1):47–51
3. De Bock V, Verbeelen D, Maes V, Sennesael J (1989) Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration. Nephrol Dial Transplant 4(7):635–639
4. Vincent HH, Vos MC, Akçahuseyin E, Goessens WH, van Duyl WA, Schalekamp MA (1993) Drug clearance by continuous haemodiafiltration. Analysis of sieving coefficients and mass transfer coefficients of diffusion. Blood Purif 11(2):99–107
5. Pea F, Viale P, Pavan F, Furlanut M (2007) Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 46(12):997–1038